Mandle Hannah B, Cahill Kaitlyn E, Fowler Kristen M, Hauser W Allen, Davis Anne R, Herzog Andrew G
Harvard Neuroendocrine Unit, Beth Israel Deaconess Medical Center, Boston, Massachusetts, U.S.A.
Gertrude H. Sergievsky Center, Mailman School of Public Health, Columbia University, New York, New York, U.S.A.
Epilepsia. 2017 May;58(5):907-914. doi: 10.1111/epi.13734. Epub 2017 Apr 3.
To report the reasons for discontinuation of contraceptive methods by women with epilepsy (WWE).
These retrospective data come from a web-based survey regarding the contraceptive practices of 1,144 WWE in the community, ages 18-47 years. We determined the frequencies of contraceptive discontinuations and the reasons for discontinuation. We compared risk ratios for rates of discontinuation among contraceptive methods and categories. We used chi-square analysis to test the independence of discontinuation reasons among the various contraceptive methods and categories and when stratified by antiepileptic drug (AED) categories.
Nine hundred fifty-nine of 2,393 (40.6%) individual, reversible contraceptive methods were discontinued. One-half (51.8%) of the WWE who discontinued a method discontinued at least two methods. Hormonal contraception was discontinued most often (553/1,091, 50.7%) with a risk ratio of 1.94 (1.54-2.45, p < 0.0001) compared to intrauterine devices (IUDs), the category that was discontinued the least (57/227, 25.1%). Among all individual methods, the contraceptive patch was stopped most often (79.7%) and the progestin-IUD was stopped the least (20.1%). The top three reasons for discontinuation among all methods were reliability concerns (13.9%), menstrual problems (13.5%), and increased seizures (8.6%). There were significant differences among discontinuation rates and reasons when stratified by AED category for hormonal contraception but not for any other contraceptive category.
Contraception counseling for WWE should consider the special experience profiles that are unique to this special population on systemic hormonal contraception.
报告癫痫女性(WWE)停用避孕方法的原因。
这些回顾性数据来自一项关于1144名社区中18至47岁WWE避孕做法的网络调查。我们确定了避孕方法停用的频率及停用原因。我们比较了不同避孕方法和类别之间停用率的风险比。我们使用卡方分析来检验不同避孕方法和类别之间以及按抗癫痫药物(AED)类别分层时停用原因的独立性。
在2393种个体可逆避孕方法中,有959种(40.6%)被停用。停用一种方法的WWE中有一半(51.8%)至少停用了两种方法。激素避孕法停用最为频繁(553/1091,50.7%),与停用最少的宫内节育器(IUD)类别(57/227,25.1%)相比,风险比为1.94(1.54 - 2.45,p < 0.0001)。在所有个体方法中,避孕贴片停用最为频繁(79.7%),而孕激素宫内节育器停用最少(20.1%)。所有方法中停用的前三大原因是对可靠性的担忧(13.9%)、月经问题(13.5%)和癫痫发作增加(8.6%)。按AED类别对激素避孕法进行分层时,停用率和原因存在显著差异,但对任何其他避孕类别则无差异。
对WWE的避孕咨询应考虑该特殊人群在系统性激素避孕方面独特的特殊经历概况。